Adrenomedullin: a new and promising target for drug discovery

Bibliography

• KITAMURA K, KANGAWA K, KAWAMOTO M et al.: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. (1993) 192:553-560.
   PubMed Web of Science ®Google Scholar
• LOPEZ J, CUESTA N: Adrenomedullin as a pancreatic hormone. Microsc. Res. Tech. (2002) 57(2):61-75.
   PubMedGoogle Scholar
• JULIAN M, CACHO M, GARCIA MA et al.: Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur. J. Med. Chem. (2005) 40(8):737-750.
   PubMedGoogle Scholar
• ROH J, CHANG CL, BHALLA A, KLEIN C, HSU SY: Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J. Biol. Chem. (2004) 279:7264-7274.
   PubMed Web of Science ®Google Scholar
• POYNER DR, SEXTON PM, MARSHALL I et al.: The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. (2002) 54:233-246.
   PubMed Web of Science ®Google Scholar
• ZUDAIRE E, CUESTA N, MARTINEZ A, CUTTITTA F: Characterization of adrenomedullin in birds. Gen. Comp. Endocrinol. (2005) 143(1):10-20.
   PubMedGoogle Scholar
• BUNTON DC, PETRIE MC, HILLIER C, JOHNSTON F, MCMURRAY JJV: The clinical relevance of adrenomedullin: a promising profile? Pharmacol. Ther. (2004) 103(3):179-201.
   PubMed Web of Science ®Google Scholar
• KITAMURA K, SAKATA J, KANGAWA K et al.: Cloning and characterization of cDNA encoding a precursor for human adrenomedullin [published erratum appears in Biochem. Biophys. Res. Commun. (1994) 202(1):643]. Biochem. Biophys. Res. Commun. (1993) 194:720-725.
   PubMed Web of Science ®Google Scholar
• LOPEZ J, MARTINEZ A: Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int. Rev. Cytol. (2002) 221:1-92.
   PubMed Web of Science ®Google Scholar
• MARTINEZ A, HODGE DL, GARAYOA M, YOUNG HA, CUTTITTA F: Alternative splicing of the proadrenomedullin gene results in differential expression of gene products. J. Mol. Endocrinol. (2001) 27(1):31-41.
   PubMedGoogle Scholar
• BELTOWSKI J, JAMROZ A: Adrenomedullin – What do we know 10 years since its discovery? Pol. J. Pharmacol. (2004) 56(1):5-27.
   PubMedGoogle Scholar
• PIO R, MARTINEZ A, UNSWORTH EJ et al.: Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J. Biol. Chem. (2001) 276:12292-12300.
   PubMed Web of Science ®Google Scholar
• DUPUIS J, CARON A, RUEL N: Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin. Clin. Sci. (Lond) (2005) 109(1):97-102.
   PubMed Web of Science ®Google Scholar
• MUFF R, BORN W, FISCHER JA: Adrenomedullin and related peptides: receptors and accessory proteins. Peptides (2001) 22:1765-1772.
   PubMedGoogle Scholar
• HAY DL, SMITH DM: Adrenomedullin receptors: molecular identity and function. Peptides (2001) 22(11):1753-1763.
   PubMedGoogle Scholar
• NJUKI F, NICHOLL CG, HOWARD A et al.: A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin. Sci. (Lond) (1993) 85(4):385-388.
   PubMed Web of Science ®Google Scholar
• POYNER DR: Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin. Biochem. Soc. Trans. (1997) 25(3):1032-1036.
   PubMed Web of Science ®Google Scholar
• UDAWELA M, HAY DL, SEXTON PM: The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin. Cell Dev. Biol. (2004) 15(3):299-308.
   PubMedGoogle Scholar
• BUHLMANN N, LEUTHAUSER K, MUFF R, FISCHER JA, BORN W: A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology (1999) 140:2883-2890.
   PubMedGoogle Scholar
• HAY DL, HOWITT SG, CONNER AC et al.: CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br. J. Pharmacol. (2003) 140(3):477-486.
   PubMed Web of Science ®Google Scholar
• BOMBERGER JM, PARAMESWARAN N, HALL CS, AIYAR N, SPIELMAN WS: Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J. Biol. Chem. (2005) 280(10):9297-9307.
   PubMed Web of Science ®Google Scholar
• BOMBERGER JM, SPIELMAN WS, HALL CS, WEINMAN EJ, PARAMESWARAN N: Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J. Biol. Chem. (2005) 280(25):23926-23935.
   PubMed Web of Science ®Google Scholar
• HIRATA Y, HAYAKAWA H, SUZUKI Y et al.: Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension (1995) 25(4 Pt 2):790-795.
   PubMedGoogle Scholar
• AIYAR N, DISA J, DANG K et al.: Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors. Eur. J. Pharmacol. (2000) 403(1-2):1-7.
   PubMedGoogle Scholar
• PARAMESWARAN N, AIYAR N, WU H et al.: Desensitization and resensitization of adrenomedullin-sensitive receptor in rat mesangial cells. Eur. J. Pharmacol. (2000) 407(3):205-210.
   PubMedGoogle Scholar
• KUWASAKO K, SHIMEKAKE Y, MASUDA M et al.: Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. (2000) 275(38):29602-29609.
   PubMed Web of Science ®Google Scholar
• ALLAKER RP, ZIHNI C, KAPAS S: An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol. Med. Microbiol. (1999) 23:289-293.
   PubMed Web of Science ®Google Scholar
• SERRANO J, ALONSO D, ENCINAS JM et al.: Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience (2002) 109(4):717-731.
   PubMedGoogle Scholar
• JUANEDA C, DUMONT Y, CHABOT JG, FOURNIER A, QUIRION R: Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur. J. Pharmacol. (2003) 474(2-3):165-174.
   PubMedGoogle Scholar
• GOTO K, FUJII K, ONAKA U, ABE I, FUJISHIMA M: Effects of adrenomedullin and PAMP on membrane potential and neurotransmission. Peptides (2000) 21(2):257-263.
   PubMedGoogle Scholar
• SMITH PM, FERGUSON AV: Adrenomedullin acts in the rat paraventricular nucleus to decrease blood pressure. J. Neuroendocrinol. (2001) 13:467-471.
   PubMedGoogle Scholar
• SERRANO J, ALONSO D, FERNANDEZ AP et al.: Adrenomedullin in the central nervous system. Microsc. Res. Tech. (2002) 57(2):76-90.
   PubMedGoogle Scholar
• FUJIOKA H, OKAMURA T, TODA N: Inhibition by adrenomedullin of amine release from adrenergic nerves in dog mesenteric arteries. Eur. J. Pharmacol. (1999) 385(2-3):155-161.
   PubMedGoogle Scholar
• NISHIKIMI T, MATSUOKA H: Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr. Med. Chem. Cardiovasc. Hematol. Agents (2005) 3(3):231-242.
   PubMedGoogle Scholar
• SHIMOSAWA T, FUJITA T: Adrenomedullin and its related peptide. Endocr. J. (2005) 52(1):1-10.
   PubMedGoogle Scholar
• SAITA M, ISHIZUKA Y, KATO K et al.: Cardiovascular and sympathetic effects of proadrenomedullin NH2-terminal 20 peptide in conscious rats. Regul. Pept. (1998) 77:147-153.
   PubMedGoogle Scholar
• SAITA M, SHIMOKAWA A, KUNITAKE T et al.: Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am. J. Physiol. (1998) 274:R979-R984.
   Google Scholar
• SATO A, CANNY BJ, AUTELITANO DJ: Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem. Biophys. Res. Commun. (1997) 230(2):311-314.
   PubMedGoogle Scholar
• ISHIMITSU T, NISHIKIMI T, SAITO Y et al.: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. (1994) 94(5):2158-2161.
   PubMed Web of Science ®Google Scholar
• KATO J, KOBAYASHI K, ETOH T et al.: Plasma adrenomedullin concentration in patients with heart failure. J. Clin. Endocrinol. Metab. (1996) 81(1):180-183.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI K, KITAMURA K, HIRAYAMA N et al.: Increased plasma adrenomedullin in acute myocardial infarction. Am. Heart J. (1996) 131(4):676-680.
   PubMed Web of Science ®Google Scholar
• MORENO MJ, ABOUNADER R, HEBERT E, DOODS H, HAMEL E: Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology (2002) 42(4):568-576.
   PubMed Web of Science ®Google Scholar
• NOSSAMAN BD, KAYE AD, CHAMPION HC, DEWITT B, KADOWITZ PJ: Analysis of responses to adrenomedullin in the pulmonary vascular bed. In: Adrenomedullin, (Washington, D.C.): IQS Press and Ohmsha, (1998):143-157.
   Google Scholar
• NISHIKIMI T, MATSUOKA H, SHIMADA K, MATSUO H, KANGAWA K: Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am. J. Hypertens. (2000) 13(9):1032-1034.
   PubMedGoogle Scholar
• OHBAYASHI H, SUITO H, YOSHIDA N et al.: Adrenomedullin inhibits ovalbumin-induced bronchoconstriction and airway microvascular leakage in guinea-pigs. Eur. Respir. J. (1999) 14(5):1076-1081.
   PubMedGoogle Scholar
• CUZZOLA F, MALLAMACI F, TRIPEPI G et al.: Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Am. J. Hypertens. (2001) 14(3):224-230.
   PubMedGoogle Scholar
• LAINCHBURY JG, TROUGHTON RW, LEWIS LK et al.: Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J. Clin. Endocrinol. Metab. (2000) 85(3):1016-1020.
   PubMed Web of Science ®Google Scholar
• NAKAMURA Y, SHIMATSU A, MURABE H et al.: Calcitonin gene-related peptide as a GH secretagogue in human and rat pituitary somatotrophs. Brain Res. (1998) 807(1-2):203-207.
   PubMedGoogle Scholar
• SAMSON WK: Adrenomedullin and the control of fluid and electrolyte homeostasis. Ann. Rev. Physiol. (1999) 61:363-389.
   PubMed Web of Science ®Google Scholar
• NUSSDORFER GG: Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis. Int. Rev. Cytol. (2001) 206:249-284.
   PubMedGoogle Scholar
• KAPAS S, MARTINEZ A, CUTTITTA F, HINSON JP: Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J. Endocrinol. (1998) 156:477-484.
   PubMed Web of Science ®Google Scholar
• MAZZOCCHI G, MUSAJO F, NERI G, GOTTARDO G, NUSSDORFER GG: Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ: comparison with calcitonin gene-related peptide effects. Peptides (1996) 17(5):853-857.
   PubMed Web of Science ®Google Scholar
• MARTINEZ A, WEAVER C, LOPEZ J et al.: Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology (1996) 137(6):2626-2632.
   PubMedGoogle Scholar
• MARTINEZ A, CUTTITTA F: Adrenomedullin, pancreatic islets, and diabetes. Can. J. Diabetes Care (2000) 24:38-46.
   Google Scholar
• MARTINEZ A, PIO R, LOPEZ J, CUTTITTA F: Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion. J. Endocrinol. (2001) 170(3):503-511.
   PubMedGoogle Scholar
• ZUDAIRE E, CUTTITTA F, MARTINEZ A: Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regul. Pept. (2003) 112(1-3):121-130.
   PubMedGoogle Scholar
• SAMSON WK, VARI RC, RESCH ZT, MURPHY TC: Adrenomedullin and fluid and electrolyte homeostasis. In: Adrenomedullin, (Washington, D. C.): IQS Press and Ohmsha, (1998):159-170.
   Google Scholar
• CHARLES CJ, RADEMAKER MT, RICHARDS AM et al.: Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. Endocrinology (1998) 139:1746-1751.
   PubMedGoogle Scholar
• MONTUENGA LM, BURRELL MA, GARAYOA M et al.: Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes. J. Neuroendocrinol. (2000) 12(7):607-617.
   PubMedGoogle Scholar
• MACRI CJ, LOUP D, MCHALE M et al.: Adrenomedullin is widely expressed throughout normal and abnormal reproductive tissues of women. In: Adrenomedullin, (Washington, D.C.): IQS Press and Ohmsha, (1998):207-226.
   Google Scholar
• OEHLER MK, NORBURY C, HAGUE S, REES MC, BICKNELL R: Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene (2001) 20(23):2937-2945.
   PubMed Web of Science ®Google Scholar
• CASEY ML, SMITH J, ALSABROOK G, MACDONALD PC: Activation of adenylyl cyclase in human myometrial smooth muscle cells by neuropeptides. J. Clin. Endocrinol. Metab. (1997) 82(9):3087-3092.
   PubMedGoogle Scholar
• KAUFMAN S, DENG Y: Adrenomedullin suppresses atrial natriuretic factor (ANF) secretion from isolated atrium. Life Sci. (1998) 63(12):1017-1022.
   PubMedGoogle Scholar
• BIVALACQUA TJ, RAJASEKARAN M, CHAMPION HC et al.: The influence of castration on pharmacologically induced penile erection in the cat. J. Androl. (1998) 19(5):551-557.
   PubMedGoogle Scholar
• MARTINEZ A, ELSASSER TH, MURO-CACHO C et al.: Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology (1997) 138(12):5597-5604.
   PubMed Web of Science ®Google Scholar
• KATO H, SHICHIRI M, MARUMO F, HIRATA Y: Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology (1997) 138(6):2615-2620.
   PubMed Web of Science ®Google Scholar
• SHICHIRI M, KATO H, DOI M, MARUMO F, HIRATA Y: Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol. Endocrinol. (1999) 13(8):1353-1363.
   PubMedGoogle Scholar
• SATA M, KAKOKI M, NAGATA D et al.: Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via cyclic GMP-independent mechanism. Hypertension (2000) 36(1):83-88.
   PubMedGoogle Scholar
• REBUFFAT P, FORNERIS ML, ARAGONA F et al.: Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland: evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells. Int. J. Mol. Med. (2002) 9(2):119-1124.
   PubMedGoogle Scholar
• MARTINEZ A, VOS M, GUEDEZ L et al.: The effects of adrenomedullin overexpresion in breast tumor cells. J. Natl. Cancer Inst. (2002) 94(16):1226-1237.
   PubMedGoogle Scholar
• WALSH T, MARTINEZ A, PETER J, UNSWORTH E, CUTTITTA F: Antimicrobial activity of adrenomedullin and its gene related peptides. Clin. Infect. Dis. (1996) 23:877.
   Google Scholar
• ALLAKER RP, GROSVENOR PW, MCANERNEY DC et al.: Mechanisms of adrenomedullin antimicrobial action. Peptides (2005) Epub ahead of print.
   PubMedGoogle Scholar
• CORNISH J, CALLON KE, COY DH et al.: Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. (1997) 273:E1113-E1120.
   Web of Science ®Google Scholar
• CORNISH J, CALLON KE, BAVA U et al.: Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice. J. Endocrinol. (2001) 170:251-257.
   PubMedGoogle Scholar
• UZAN B, DE VERNEJOUL M, CRESSENT M: RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment. Biochem. Biophys. Res. Commun. (2004) 321(4):802-808.
   PubMed Web of Science ®Google Scholar
• CHIRGWIN J, MOHAMMAD K, GUISE T: Tumor-bone cellular interactions in skeletal metastases. J. Musculoskelet. Neuronal Interact. (2004) 4(3):308-318.
   PubMedGoogle Scholar
• SUGANO T, TSUJI H, MASUDA H et al.: Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. (2001) 21(6):1078-1083.
   PubMedGoogle Scholar
• KOHNO M, HANEHIRA T, KANO H et al.: Plasma adrenomedullin concentrations in essential-hypertension. Hypertension (1996) 27:102-107.
   PubMed Web of Science ®Google Scholar
• SUMIMOTO T, NISHIKIMI T, MUKAI M et al.: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension (1997) 30:741-745.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI K, KITAMURA K, ETOH T et al.: Increased plasma adrenomedullin levels in chronic congestive heart failure. Am. Heart J. (1996) 131:994-998.
   PubMed Web of Science ®Google Scholar
• ZHANG JJ, YOSHIDA H, CHAO L, CHAO J: Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis and renal damage in hypertensive Dahl salt-sensitive rats. Hum. Gene Ther. (2000) 11:1817-1827.
   PubMedGoogle Scholar
• CHAO J, JIN L, LIN KF, CHAO L: Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats [published erratum appears in Hypertens Res 1999 Sep;22(3):229]. Hypertens. Res. (1997) 20(4):269-277.
   PubMedGoogle Scholar
• MORI Y, NISHIKIMI T, KOBAYASHI N et al.: Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension (2002) 40:107-113.
   PubMedGoogle Scholar
• WANG C, DOBRZYNSKI E, CHAO J, CHAO L: Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am. J. Physiol Renal. Physiol. (2001) 280:F964-F971.
   PubMed Web of Science ®Google Scholar
• ISHIYAMA Y, KITAMURA K, ICHIKI Y et al.: Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur. J. Pharmacol. (1993) 241(2-3):271-273.
   PubMed Web of Science ®Google Scholar
• LAINCHBURY JG, COOPER GJ, COY DH et al.: Adrenomedullin: a hypotensive hormone in man. Clin. Sci. (Lond) (1997) 92(5):467-472.
   Google Scholar
• ETO T, KITAMURA K, KATO J: Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin. Exp. Pharmacol. Physiol. (1999) 26(5-6):371-380.
   PubMedGoogle Scholar
• BIECKER E, SAGESSER H, REICHEN J: Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice. Eur. J. Clin. Invest. (2004) 34:283-289.
   PubMedGoogle Scholar
• YOSHITOMI Y, NISHIKIMI T, KOJIMA S et al.: Plasma levels of adrenomedullin in patients with acute myocardial infarction. Clin. Sci. (1998) 94:135-139.
   Google Scholar
• KAMIYA H, OKUMURA K, SONE T et al.: Plasma adrenomedullin levels in the coronary circulation in vasospastic angina pectoris. Am. J. Cardiol. (2000) 85:656-658.
   PubMedGoogle Scholar
• KATO K, YIN H, AGATA J et al.: Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. (2003) 285:1506-1514.
   PubMed Web of Science ®Google Scholar
• OKUMURA H, NAGAYA N, KANGAWA K: Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats. Hypertens. Res. (2003) 26:S99-S104.
   Google Scholar
• YIN H, CHAO L, CHAO J: Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension (2004) 43:109-116.
   PubMedGoogle Scholar
• JOUGASAKI M, STEVENS TL, BORGESON DD, LUCHNER A, BURNETT JC: Adrenomedullin in the evolution of experimental heart failure. J. Am. Coll. Cardiol. (1997) 29:8053.
   Google Scholar
• ETOH T, KATO J, TAKENAGA M et al.: Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Clin. Cardiol. (1999) 22:113-117.
   PubMedGoogle Scholar
• RADEMAKER MT, CHARLES CJ, LEWIS LK et al.: Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation (1997) 96(6):1983-1990
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Adrenomedullin regulates insulin secretion and glucose metabolism. Summer Neuropeptide Conference (1999), Key West, Florida, USA.
   Google Scholar
• MARTINEZ A, ELSASSER TH, BHATHENA SJ et al.: Is adrenomedullin a causal agent in some cases of Type 2 diabetes? Peptides (1999) 20(12):1471-1478.
   PubMed Web of Science ®Google Scholar
• HAYASHI M, SHIMOSAWA T, ISAKA M et al.: Plasma adrenomedullin in diabetes [letter]. Lancet (1997) 350(9089):1449-1450.
   PubMed Web of Science ®Google Scholar
• NAKAMURA T, HONDA K, ISHIKAWA S et al.: Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: close relationships with diabetic complications. Endocr. J. (1998) 45(2):241-246.
   PubMed Web of Science ®Google Scholar
• HAYASHI M, SHIMOSAWA T, FUJITA T: Hyperglycemia increases vascular adrenomedullin expression. Biochem. Biophys. Res. Commun. (1999) 258(2):453-456.
   PubMed Web of Science ®Google Scholar
• KINOSHITA H, KATO K, KUROKI M et al.: Plasma adrenomedullin levels in patients with diabetes. Diabetes Care (2000) 23(2):253-254.
   PubMedGoogle Scholar
• GARCIA-UNZUETA MT, MONTALBAN C, PESQUERA C, BERRAZUETA JR, AMADO JA: Plasma adrenomedullin levels in Type 1 diabetes: relationship with clinical parameters. Diabetes Care (1998) 21(3):999-1003.
   PubMedGoogle Scholar
• GARCIA-UNZUETA MT, BERRAZUETA JR, PESQUERA C et al.: Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes – Adrenomedullin and vascular risk factors in Type 1 DM. J. Diabetes Complications (2005) 19(3):147-154.
   PubMedGoogle Scholar
• SHIMOSAWA T, MATSUI H, XING G et al.: Organ-protective effects of adrenomedullin. Hypertens. Res. (2003) 26(Suppl.):S109-S112.
   Google Scholar
• KATSUKI A, SUMIDA Y, URAKAWA H et al.: Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with Type 2 diabetes. Diabetes Care (2003) 26:1642-1643.
   PubMed Web of Science ®Google Scholar
• WU JT: Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications. J. Clin. Lab. Anal. (1993) 7(5):293-300.
   PubMed Web of Science ®Google Scholar
• SHIMOSAWA T, OGIHARA T, MATSUI H et al.: Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension (2003) 41:1080-1085.
   PubMedGoogle Scholar
• ZUDAIRE E, MARTINEZ A, CUTTITTA F: Adrenomedullin and cancer. Regul. Pept. (2003) 112:175-183.
   PubMedGoogle Scholar
• SATOH F, TAKAHASHI K, MURAKAMI O et al.: Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J. Clin. Endocrinol. Metab. (1995) 80:1750-1752.
   PubMedGoogle Scholar
• MARTINEZ A, MILLER MJ, UNSWORTH EJ, SIEGFRIED JM, CUTTITTA F: Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology (1995) 136:4099-4105.
   PubMedGoogle Scholar
• MILLER MJ, MARTINEZ A, UNSWORTH EJ et al.: Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J. Biol. Chem. (1996) 271:23345-23351.
   PubMed Web of Science ®Google Scholar
• ALBERTIN G, CARRARO G, PETRELLI L et al.: Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. Int. J. Mol. Med. (2005) 15(3):469-474.
   PubMedGoogle Scholar
• BOUDOURESQUE F, BERTHOIS Y, MARTIN PM et al.: Role of adrenomedullin in glioblastomas growth. Bull. Cancer (Paris). (2005) 92(4):317-326.
   PubMedGoogle Scholar
• ABASOLO I, MONTUENGA LM, CALVO A: Adrenomedullin prevents apoptosis in prostate cancer cells. Regul. Pept. (2006) 133(1-3):115-122.
   PubMedGoogle Scholar
• ABASOLO I, WANG Z, MONTUENGA LM, CALVO A: Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism. Biochem. Biophys. Res. Commun. (2004) 322(3):878-886.
   PubMedGoogle Scholar
• PIO R, MARTINEZ A, ELSASSER T, CUTTITTA F: Presence of inmunoreactive adrenomedullin in human and bovine milk. Peptides (2000) 21:1859- 1863.
   PubMed Web of Science ®Google Scholar
• MAZZOCCHI G, MALENDOWICZ LK, ZIOLKOWSKA A et al.: Adrenomedullin (AM) and AM receptor Type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates. Int. J. Oncol. (2004) 25(6):1781-1787.
   PubMed Web of Science ®Google Scholar
• OUAFIK L, SAUZE S, BOUDOURESQUE F et al.: Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am. J. Pathol. (2002) 160(4):1279-1292.
   PubMed Web of Science ®Google Scholar
• OEHLER MK, HAGUE S, REES MC, BICKNELL R: Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene (2002) 21(18):2815-2821.
   PubMed Web of Science ®Google Scholar
• ZHAO Y, HAGUE S, MANEK S et al.: PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene (1998) 16(3):409-415.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ-SAUZE S, DELFINO C, MABROUK K et al.: Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int. J. Cancer (2004) 108:797-804.
   PubMed Web of Science ®Google Scholar
• TOKUNAGA N, NAGAYA N, SHIRAI M et al.: Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin. Circulation (2004) 109:526-531.
   PubMed Web of Science ®Google Scholar
• KIM W, MOON SO, SUNG MJ et al.: Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J. (2003) 17(13):1937-1939.
   PubMedGoogle Scholar
• RIBATTI D, NICO B, SPINAZZI R, VACCA A, NUSSDORFER GG: The role of adrenomedullin in angiogenesis. Peptides (2005) 26(9):1670-1675.
   PubMedGoogle Scholar
• NAGAYA N, MORI H, MURAKAMI S, KANGAWA K, KITAMURA S: Adrenomedullin: angiogenesis and gene therapy. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2005) 288(6):R1432-R1437.
   Web of Science ®Google Scholar
• NIKITENKO LL, SMITH DM, BICKNELL R, REES MC: Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. FASEB J. (2003) 17(11):1499-1501.
   PubMedGoogle Scholar
• GARAYOA M, MARTINEZ A, LEE S et al.: Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. (2000) 14(6):848-862.
   PubMed Web of Science ®Google Scholar
• ISHIKAWA T, CHEN J, WANG JX et al.: Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene (2003) 22(8):1238-1242.
   PubMed Web of Science ®Google Scholar
• KAMOI H, KANAZAWA H, HIRATA K et al.: Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. (1995) 211(3):1031-1035.
   PubMedGoogle Scholar
• OZBEK E, YUREKLI M, SOYLU A, DAVARCI M, BALBAY MD: The role of adrenomedullin in varicocele and impotence. BJU Int. (2000) 86(6):694-698.
   PubMedGoogle Scholar
• MARTINEZ V, CUTTITTA F, TACHE Y: Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology (1997) 138(9):3749-3755.
   PubMed Web of Science ®Google Scholar
• CLEMENTI G, CARUSO A, CUTULI VMC et al.: Gastroprotective effect of adrenomedullin administered subcutaneously in the rat. Peptides (2002) 23(6):1149-1153.
   PubMed Web of Science ®Google Scholar
• SALOMONE S, CARUSO A, MARTINEZ G et al.: Secretory and vascular effects of adrenomedullin in gastric ulcer: role of CGRP- and adrenomedullin-receptors. Peptides (2003) 24(8):1175-1180.
   PubMedGoogle Scholar
• NAOT D, CALLON KE, GREY A et al.: A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology (2001) 142:1849-1857.
   PubMedGoogle Scholar
• ONITSUKA H, IMAMURA T, ITO K et al.: Differential gene expression of adrenomedullin receptors in pressure- and volume-overloaded heart – role of angiotensin II. Peptides (2004) 25(7):1107-1114.
   PubMedGoogle Scholar
• LI YY, CHEUNG BMY, WONG LYF et al.: Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide. Neuropeptides (2005) 39(2):73-80.
   PubMedGoogle Scholar
• FREDE S, FREITAG P, OTTO T, HEILMAIER C, FANDREY J: The proinflammatory cytokine interleukin 1 beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res. (2005) 65(11):4690-4697.
   PubMed Web of Science ®Google Scholar
• ONITSUKA H, IMAMURA T, YAMAGA J et al.: Angiotensin II stimulates cardiac adrenomedullin production and causes accumulation of mature adrenomedullin independently of hemodynamic stress in vivo. Horm. Metab. Res. (2005) 37(5):281-285.
   PubMedGoogle Scholar
• OZAWA N, SHICHIRI M, FUKAI N, YOSHIMOTO T, HIRATA Y: Regulation of adrenomedullin gene transcription and degradation by the c-myc gene. Endocrinology (2004) 145(9):4244-4250.
   PubMed Web of Science ®Google Scholar
• ALBERTIN G, CARRARO G, NUSSDORFER GG: Human adrenomedullin gene silencing by short interfering RNAs: A preliminary study. Int. J. Mol. Med. (2005) 15(4):579-583.
   PubMedGoogle Scholar
• ALBERTIN G, RUCINSKI M, CARRARO G et al.: Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells. Int. J. Mol. Med. (2005) 16(3):431-435.
   PubMedGoogle Scholar
• MISHIMA K, KATO J, KUWASAKO K et al.: Angiotensin II modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes. Life Sci. (2003) 73(13):1629-1635.
   PubMedGoogle Scholar
• THOTA C, YALLAMPALLI C: Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3‘ 5‘-monophosphate generation in eker rat uterine smooth muscle cell line. Biol. Reprod. (2005) 72(2):416-422.
   PubMed Web of Science ®Google Scholar
• MARTINEZ A, OH HR, UNSWORTH EJ et al.: Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem. J. (2004) 383:413-418.
   PubMed Web of Science ®Google Scholar
• GARCIA MA, MARTIN-SANTAMARIA S, CACHO M et al.: Synthesis, biological evaluation, and three-dimensional quantitative structure-activity relationship study of small-molecule positive modulators of adrenomedullin. J. Med. Chem. (2005) 48(12):4068-4075.
   PubMedGoogle Scholar
• MARTINEZ A, JULIAN M, BREGONZIO C et al.: Identification of vasoactive non-peptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology (2004) 145:3858-3865.
   PubMed Web of Science ®Google Scholar
• BALAT A, KILINC M, CEKMEN MB et al.: Adrenomedullin and total nitrite levels in children with acute rheumatic fever. Clin. Biochem. (2005) 38(6):526-530.
   PubMedGoogle Scholar
• GUMUSEL B, CHANG JK, HYMAN A, LIPPTON H: Adrenotensin: an ADM gene product with the opposite effects of ADM. Life Sci. (1995) 57(8):L87-L90.
   Google Scholar
• CHAMPION HC, FRIEDMAN DE, LAMBERT DG et al.: Adrenomedullin (16-31) has pressor activity in the rat but not the cat. Peptides (1997) 18(1):133-136.
   PubMed Web of Science ®Google Scholar
• TAKEI Y, INOUE K, OGOSHI M et al.: Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett. (2004) 556(1-3):53-58.
   PubMed Web of Science ®Google Scholar
• NAGAYA N, GOTO Y, SATOH T et al.: Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J. Cardiovasc. Pharmacol. (2002) 39(5):754-760.
   PubMed Web of Science ®Google Scholar
• NAGAYA N, SATOH T, NISHIKIMI T et al.: Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation (2000) 101(5):498-503.
   PubMed Web of Science ®Google Scholar
• NAGAYA N, NISHIKIMI T, UEMATSU M et al.: Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart (2000) 84(6):653-658.
   PubMed Web of Science ®Google Scholar
• ZUDAIRE E, MARTINEZ A, GARAYOA M et al.: Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am. J. Pathol. (2006) 168(1):280-291.
   PubMed Web of Science ®Google Scholar